Cambrian Biopharma News and Activities
Presence
Cambrian Biopharma develops medicines for age-related diseases. It provides drug discovery, clinical development, and biotech platform services for patients, healthcare partners, and research investors.
Cambrian Biopharma products and services overview:
- Drug development
- Longevity therapies
- Clinical programs
- Biotech platforms
Revenue: ~$10 million
Employees: 60
Headquarters: New York, United States (USA)
Cambrian Biopharma is one of the...
Executives
View the org chart displaying its 19 main executives
Most searched biographies at Cambrian Biopharma
- James Peyer, Co-Founder, Chief Executive Officer and Director
- Paul Farr, Director
- Brent Saunders, Director
Create your alert
to follow the executive moves at Cambrian Biopharma.
Biotechnology
Cambrian Biopharma has 2,406 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).
Popular M&A news in Biotechnology
- Laboratoire Servier has announced the acquisition of Edgewise Therapeutics (posted on June 4 2026).
- Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
- IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
Popular contacts in Biotechnology
News
Press releases by Cambrian Biopharma
- Cambrian Bio
- Cambrian Bio
- Cambrian Bio
- Granata Bio Expands Women's Health Portfolio with Acquisition of US-Based Oviva Therapeutics — Granata Bio
- Cambrian Bio
- News and Publications
- Cambrian Bio
- Cambrian Bio
- Cambrian Bio
- Cambrian Bio
- View more press releases Close
Social media about Cambrian Biopharma
- Cambrian Biopharma on Wikipedia, Google News & Yahoo Finance
- Cambrian Biopharma on LinkedIn, X (Twitter) & YouTube
